Braintree Beats Colon-Cleanser Patent Invalidity Claims

Law360, New York (June 5, 2013, 1:32 PM EDT) -- A New Jersey federal judge said Tuesday that Braintree Laboratories Inc.'s patent on Suprep is valid, a ruling that follows the judge's finding in January that Novel Laboratories Inc.'s plan to make a generic version of the colon cleanser infringed the patent.

U.S. District Judge Peter G. Sheridan struck down various arguments that Braintree's U.S. Patent Number 6,946,149 was invalid, finding that Novel had not presented convincing enough evidence to back its invalidity claims. The '149 patent covers Braintree's Suprep, a laxative formula used to clear...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.